New Type Of Drug To Prevent Migraines Heads To Market
An antibody-based drug reduces the frequency of migraine headaches, according to data reviewed by the Food and Drug Administration. The agency approved Aimovig, priced at about $6,900 a year.
Read more on NPR
No comments:
Post a Comment